Clorazepate Dipotassium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

11 Suppliers, 7 USDMF, 2 CEP/COS, 1 JDMF, 3 NDC API, 5 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

114 Dossiers, 85 FDA Orange Book, 25 Europe, 3 Canada, 1 South Africa

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 10 Sigachi Industries, 8 Roquette, 8 Microlex e.U, 6 Gangwal Healthcare, 5 Gangwal Chemicals, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 3 Kerry, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Vasa Pharmachem, 3 Prachin Chemical, 3 DFE Pharma, 2 Actylis, 1 Ingredion Pharma Solutions, 1 Finar, 1 Pharmatrans-Sanaq, 1 Ideal Cures Pvt Ltd, 1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders, 16 Disintegrants & Superdisintegrants, 14 Lubricants & Glidants, 13 Direct Compression, 10 Thickeners and Stabilizers, 9 Granulation, 7 Controlled & Modified Release, 6 Co-Processed Excipients, 5 Coating Systems & Additives, 4 Taste Masking, 4 Parenteral, 2 Film Formers & Plasticizers, 2 Rheology Modifiers, 2 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Topical

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 28 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

3 News

3 News

Approved Drug Products containing Clorazepate Dipotassium listed with Health Canada. Original Data : Health Canada Website

Clorazepate Dipotassium

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

11 Suppliers

7 USDMF

2 CEP/COS

1 JDMF

3 NDC API

5 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

114 Dossiers

85 FDA Orange Book

25 Europe

3 Canada

1 South Africa

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

10 Sigachi Industries

8 Roquette

8 Microlex e.U

6 Gangwal Healthcare

5 Gangwal Chemicals

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

3 Kerry

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Vasa Pharmachem

3 Prachin Chemical

3 DFE Pharma

2 Actylis

1 Ingredion Pharma Solutions

1 Finar

1 Pharmatrans-Sanaq

1 Ideal Cures Pvt Ltd

1 SPI Pharma

1 DKSH

1 Jai Radhe Sales

1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

22 Fillers, Diluents & Binders

16 Disintegrants & Superdisintegrants

14 Lubricants & Glidants

13 Direct Compression

10 Thickeners and Stabilizers

9 Granulation

7 Controlled & Modified Release

6 Co-Processed Excipients

5 Coating Systems & Additives

4 Taste Masking

4 Parenteral

2 Film Formers & Plasticizers

2 Rheology Modifiers

2 Emulsifying Agents

2 Chewable & Orodispersible Aids

1 API Stability Enhancers

1 Topical

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions

28 Finished Drug Prices

MARKET PLACE

2 APIs

ANALYTICAL SOLUTION(s)

3 EDQM Standards

1 USP Standards

1 Other Ref. Standards

DIGITAL CONTENT

3 News

TABLET;ORAL - 11.25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 22.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 3.75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons